Oncology Research2026，Vol.34Issue(3)：P.725-733,9.DOI:10.32604/or.2026.069227
Advances in Systemic Therapy for Unresectable Hepatocellular Carcinoma:Commentary on The Impact of the STRIDE Regimen in HIMALAYA Trial
Leenah Abdulgader 1Abdullah Esmail2
作者信息
- 1. Department of Surgery,University of Maryland Medical Center,Baltimore,MD,USA
- 2. Section of GI Oncology,Houston Methodist Neal Cancer Center,Houston Methodist Hospital,Houston,TX,USA
- 折叠
摘要
关键词
Hepatocellular carcinoma(HCC)/single tremelimumab regular interval durvalumab(STRIDE)regimen/HIMALAYA trial/overall survival/systemic therapy分类
医药卫生引用本文复制引用
Leenah Abdulgader,Abdullah Esmail..Advances in Systemic Therapy for Unresectable Hepatocellular Carcinoma:Commentary on The Impact of the STRIDE Regimen in HIMALAYA Trial[J].Oncology Research,2026,34(3):P.725-733,9.
